Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

HYTN Innovations Inc C.HYTN

Alternate Symbol(s):  HYTNF

Healthcare Cannabis
HYTN Innovations Inc. engages in the sale of cannabis products in Canada. The company offers edible cannabis, cannabis beverages, and cannabis flowers. The company is headquartered in Kelowna, Canada.


CSE:HYTN - Post by User

HYTN Innovations Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2269)
•••
  • Betteryear2X
Post by Betteryear2on May 01, 2024 9:24am
156 Views
Post# 36016949

HYTN Welcomes U.S. Recommendation to Reclassify Cannabis

HYTN Welcomes U.S. Recommendation to Reclassify CannabisVANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN “HYTN” or “The Company”), a leader in the development, formulation, and manufacturing of products containing psychoactive and psychotropic compounds including cannabis, applauds the recent formal recommendation by the U.S. Justice Department, endorsed by the Drug Enforcement Agency (DEA), to reclassify cannabis from a Schedule I to a Schedule III controlled substance.

HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, (globenewswire.com)
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities